Tegretol-XR



Indications and Reactions:

Role Indications Reactions
Primary
Convulsion 28.2%
Epilepsy 27.6%
Hypertension 6.3%
Migraine 4.8%
Trigeminal Neuralgia 4.6%
Cardiac Disorder 3.4%
Depression 3.1%
Bipolar Disorder 2.6%
Grand Mal Convulsion 2.6%
Multiple Sclerosis 2.3%
Pain 2.0%
Diabetes Mellitus 1.7%
Facial Neuralgia 1.7%
Sleep Disorder 1.7%
Anxiety 1.4%
Headache 1.4%
Petit Mal Epilepsy 1.4%
Lung Disorder 1.1%
Oligodendroglioma 1.1%
Complex Partial Seizures 0.9%
Convulsion 18.9%
Somnolence 7.7%
Weight Increased 7.0%
Fall 5.6%
Vomiting 5.6%
Thrombosis 4.9%
Trigeminal Neuralgia 4.9%
Epilepsy 4.2%
Premature Baby 4.2%
Drug Exposure During Pregnancy 3.5%
Drug Ineffective 3.5%
Feeling Abnormal 3.5%
Grand Mal Convulsion 3.5%
Myalgia 3.5%
Nausea 3.5%
Tremor 3.5%
Vision Blurred 3.5%
Weight Decreased 3.5%
Death 2.8%
Pain 2.8%
Secondary
Epilepsy 26.9%
Convulsion 21.7%
Hypertension 9.6%
Trigeminal Neuralgia 5.8%
Osteoporosis 3.8%
Migraine 3.6%
Depression 3.0%
Blood Cholesterol Increased 2.5%
Diabetes Mellitus 2.5%
Drug Use For Unknown Indication 2.2%
Lung Disorder 2.2%
Multiple Sclerosis 2.2%
Petit Mal Epilepsy 2.2%
Anxiety 1.9%
Arrhythmia 1.6%
Constipation 1.6%
Dementia Alzheimer's Type 1.6%
Facial Neuralgia 1.6%
Migraine Prophylaxis 1.6%
Pain 1.6%
Convulsion 11.1%
Weight Decreased 8.1%
Trigeminal Neuralgia 7.1%
Fall 6.1%
Impaired Driving Ability 6.1%
Premature Labour 6.1%
Somnolence 6.1%
Urinary Incontinence 6.1%
Petit Mal Epilepsy 5.1%
Vomiting 5.1%
Epilepsy 4.0%
Mouth Injury 4.0%
Tooth Loss 4.0%
Weight Increased 4.0%
Dizziness 3.0%
Drug Exposure During Pregnancy 3.0%
Nausea 3.0%
Surgery 3.0%
Trigeminal Nerve Disorder 3.0%
Accidental Exposure 2.0%
Concomitant
Convulsion 13.0%
Drug Use For Unknown Indication 12.1%
Product Used For Unknown Indication 12.1%
Epilepsy 9.7%
Pain 6.3%
Depression 5.6%
Hypertension 5.6%
Multiple Sclerosis 4.8%
Anxiety 4.3%
Bipolar Disorder 3.5%
Migraine 2.6%
Back Pain 2.4%
Contraception 2.4%
Diabetes Mellitus 2.4%
Prophylaxis 2.4%
Blood Corticotrophin Decreased 2.2%
Blood Follicle Stimulating Hormone Decreased 2.2%
Blood Luteinising Hormone Decreased 2.2%
Relapsing-remitting Multiple Sclerosis 2.0%
Sleep Disorder 2.0%
Accident 7.9%
Weight Increased 7.9%
Psychotic Disorder 6.6%
Surgery 6.6%
Type 2 Diabetes Mellitus 6.6%
Univentricular Heart 6.6%
Colitis Ischaemic 5.3%
Disorientation 5.3%
Product Substitution Issue 5.3%
Pulmonary Embolism 5.3%
Rash 5.3%
Status Epilepticus 5.3%
Arthralgia 3.9%
Convulsion 3.9%
Drug Ineffective 3.9%
Therapeutic Response Unexpected With Drug Substitution 3.9%
Alanine Aminotransferase Increased 2.6%
Asthenia 2.6%
Atrial Fibrillation 2.6%
Depressed Mood 2.6%
Interacting
Depression 21.1%
Sleep Disorder 15.8%
Schizophrenia 10.5%
Schizophrenia, Paranoid Type 10.5%
Infection 5.3%
Mood Altered 5.3%
Nausea 5.3%
Bipolar Disorder 3.5%
Thyroid Therapy 3.5%
Complex Partial Seizures 1.8%
Convulsion 1.8%
Drug Use For Unknown Indication 1.8%
Gastrointestinal Stromal Tumour 1.8%
Grand Mal Convulsion 1.8%
Headache 1.8%
Impulse-control Disorder 1.8%
Low Density Lipoprotein Increased 1.8%
Osteoporosis 1.8%
Pain 1.8%
Pyrexia 1.8%
Withdrawal Syndrome 37.5%
Urinary Tract Infection 25.0%
Hypertension 12.5%
Epilepsy 6.3%
Road Traffic Accident 6.3%
Urticaria 6.3%
Weight Increased 6.3%